BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Aptanomics Pages on BioPortfolio:

BioPortfolio - Aptanomics
Aptanomics - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/18631-Aptanomics.ht...

BioPortfolio News: Aptanomics - Aptanomics and Nanosyn collaborate ...
Aptanomics - Aptanomics and Nanosyn collaborate to... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Aptanomics_and_Nanosyn_coll...

APTANOMICS COMPLETES FUNDING TO DEVELOP NEW DRUG DISCOVERY ...
Aptanomics is a new company formed to develop drug discovery platforms based on the ... Aptanomics S.A. is a drug discovery company based on peptide aptamer ...
http://www.bioportfolio.com/news/Aptanomics_1.htm...

BioPortfolio News: Aptanomics - APTANOMICS COMPLETES FUNDING TO ...
Aptanomics - APTANOMICS COMPLETES FUNDING TO DEVELOP... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/APTANOMICS_COMPLETES_FUNDIN...

BioPortfolio News: Aptanomics - Aptanomics to validate targets and...
Aptanomics - Aptanomics to validate targets and... - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/Aptanomics_to_validate_targ...

BioPortfolio - APTANOMICS SA - Profile
View the current APTANOMICS SA Page on BioPortfolio.com. (http://www. bioportfolio.com/biocorporate/35414-APTANOMICS+SA.html). Contact Details: ...
http://www.bioportfolio.com/biocorporate/35414-APTANOMICS%2B...

BioPortfolio - Aptanomics - APTANOMICS COMPLETES FUNDING TO ...
1 Oct 2002 ... Roger Brent made Aptanomics possible and he will remain a constant source of inspiration to us in his role as ...
http://www.bioportfolio.com/news/APTANOMICS_COMPLETES_FUNDIN...

BioPortfolio - Aptanomics - Profile
Aptanomics discovers and develops new drugs in major markets of unmet ... Aptanomics has made the transition from establishing a robust discovery platform
...
http://www.bioportfolio.com/biocorporate/18631-Aptanomics.pd...

BioPortfolio - Aptanomics - Aptanomics and Nanosyn collaborate to ...
Nanosyn and Aptanomics combine their expertise in high quality chemistry and ... Under the agreement, Aptanomics will use its proprietary peptide aptamer ...
http://www.bioportfolio.com/news/Aptanomics_and_Nanosyn_coll...

BioPortfolio News: BioPortfolio Aptanomics News Search
BioPortfolio Aptanomics News Search - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/news/company/Aptanomics.html...

Results from other life science and pharmaceutical sites:

BioSpace - Aptanomics News, Search Jobs, Events
... By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search. Company Profile. Aptanomics Lyon France Phone: N/A Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=59292...

Selection and characterization of large collections of peptide ...
Aptanomics, 181-203, Avenue Jean Jaurès, 69007 Lyon, France. marc.bickle@ aptanomics.com. Peptide aptamers are combinatorial proteins that specifically
bind ...
http://www.ncbi.nlm.nih.gov/pubmed/17406388...

Selection and characterization of large collections of peptide ...
17 Aug 2006 ... Aptanomics, 181-203, Avenue Jean Jaurès, 69007 Lyon, France. ... Correspondence to: Pierre Colas1 e-mail: pierre.colas@aptanomics.com ...
http://www.nature.com/nprot/journal/v1/n3/abs/nprot.2006.32....

A universal transgene silencing method based on RNA interference
1Aptanomics and, 2INSERM U412, Ecole Normale Supérieure, 46, ... Tel: +1 33 4 72 72 86 64; Fax: +1 33 4 72 72 87 85; Email: pierre.colas/at/aptanomics.com ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC484202/...

Bioinformatic screening of human ESTs for differentially expressed ...
The authors wish to thank Sandy Jacquier for critical reading of the manuscript, Dr. Pierre Colas at Aptanomics for providing the anti-Bcl-xL antibody and ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=14...

A RasGAP SH3 Peptide Aptamer Inhibits RasGAP-Aurora Interaction ...
2Aptanomics, Lyon, France. 3Université Paris Descartes, Hôpital Necker, CNRS UMR 8147, Paris, France. 4UMR CNRS 144, Institut Curie, 26, Paris, France ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483412/...

Oncogene - Abstract of article: p53-dependent inhibition of ...
1Département Réponse et Dynamique Cellulaire, INSERM EMI0104, CEA, Grenoble cedex, France; 2Aptanomics SA, Lyon, France. Correspondence: Dr C Cochet, ...
http://www.nature.com/onc/journal/v25/n56/abs/1209722a.html...

The interaction between the measles virus nucleoprotein and the ...
They were cloned in-frame downstream the GAL4 DNA-binding domain of the pLexAGagB vector (Aptanomics) thus yielding BD-bait fusion proteins named BD-N
TAIL, ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686699/...

Oncogene - Abstract of article: Modulation of Nr-13 antideath ...
... CNRS/Université claude Bernard Lyon 1), IFR128 BioSciences Lyon-Gerland, Lyon, France; 2Aptanomics SA, 181-203 avenue Jean Jaurès, F-69007 Lyon, France
...
http://www.nature.com/onc/journal/v26/n5/abs/1209832a.html...

A universal transgene silencing method based on RNA interference.
Aptanomics and INSERM U412, Ecole Normale Supérieure, 46, allée d'Italie, 69364 Lyon Cedex 07, France. Inducible gene expression systems have contributed ...
http://www.ncbi.nlm.nih.gov/pubmed/15249598...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.